卵巢上皮癌
- 网络Epithelial Ovarian Cancer
![卵巢上皮癌](../cache/1504000.jpg)
-
血清CA(125)测定在卵巢上皮癌中的应用价值
The Practical Value that Detection of Serum CA_ ( 125 ) in Epithelial Ovarian Cancer
-
目的:探讨血清中CA125和CA199联合检测在卵巢上皮癌和子宫内膜异位症中的临床价值。
Objective : To explore the expression of CA125 and CA199 in epithelial ovarian cancer and endometriosis discuss its clinical significance .
-
卵巢上皮癌的CT诊断
CT diagnosis of carcinomas of ovary
-
CA(125)测定联合B超检查对卵巢上皮癌的诊断和预后的价值分析
Evaluation of CA_ ( 125 ) and ultrasound in diagnosis and prognosis of ovarian epithelial carcinoma
-
卵巢上皮癌术后化疗期间血清CA(125)检测与其预后关系的研究
Study on the relationship between serum CA_ ( 125 ) of postoperative chemotherapy and prognosis of epithelial ovarian carcinoma
-
分析核DNA含量、p53蛋白表达与卵巢上皮癌患者CT表现及生存期的关系。
The correlation of nuclear DNA content and p53 protein expression with CT findings and prognosis of EOT patients was analyzed .
-
Fas及其配体在卵巢上皮癌和正常卵巢上皮细胞表达的研究
Expression of Fas and Fas Ligand in normal ovarian epithelium and ovarian cancer
-
术前血清CRP测定对评估卵巢上皮癌预后的价值
Prognostic Value of Preoperative Serum C-reactive Protein in Patients with Epithelial Ovarian Cancer
-
卵巢上皮癌组织中HLA抗原和CD80的表达
Expression and clinical significance of HLA antigen and CD80 in ovarian epithelial carcinoma
-
卵巢上皮癌组织中survivin的表达及其与Fas、FasL表达的关系
Expression of Survivin in Ovarian Epithelial Carcinoma and Its Correlation with Expression of Fas and FasL
-
卵巢上皮癌组织中HLAⅠ类抗原和CD54的表达及临床意义
Expression and clinical significance of HLA class ⅰ antigens and CD54 in ovarian epithelial cancer
-
铂类耐药性卵巢上皮癌患者卵巢上皮中VEGF-C表达的研究
Expression of VEGF-C protein in platinum-resistant epithelial ovarian cancer
-
结论Survivin蛋白表达水平增高可能与卵巢上皮癌的分化转移有关。
Conclusion High expression of Survivin protein may be related with the differentiation and metastasis of epithelial ovarian carcinoma .
-
高聚金葡素辅佐化疗药物对卵巢上皮癌者外周血T细胞亚群及NK细胞活性的影响
Effects of HASL plus chemotherapy on peripheral blood T cell subsets and NK cell activity in patients with ovarian epithelial carcinoma
-
中、晚期卵巢上皮癌242例用CP、CPT、CAP三方案化疗疗效及预后分析比较
Comparative Analysis of the Results from Treatment and Prognosis on CP , CTP and CAP Regimens for Advanced Ovarian Epithelial Cancer
-
卵巢上皮癌组织中LRP和P-gp表达及其临床意义
Expression of Lung Resistance Protein and P glycoprotein and Clinical Significance in Epithelial Ovarian Tumor
-
目的:探讨溶血磷脂酸(lysophosphatidicacid,LPA)及其3种受体亚型(LPA1、LPA2、LPA3)在卵巢上皮癌发生和发展中的作用及可能机制。
Objective : To evaluate effects of lysophosphatidic acid ( LPA ) and its receptors on the carcinogenesis of epithelial ovarian carcinoma .
-
卵巢上皮癌中HLA-DR及HLA-ABC表达的临床意义
Clinical Significance of Expression of HLA-DR and HLA-ABC Antigens in Epithelial Ovarian Carcinoma
-
LPA及其受体与IL-6、IL-8在卵巢上皮癌中的表达及其临床意义
The Expression of LPA Receptors in Epithelial Ovarian Carcinoma Tissues and Plasma LPA , IL-6 and IL-8 Levels in Patients with Epithelial Ovarian Carcinoma
-
体外MTT法预测卵巢上皮癌化疗药敏性与体内疗效相关性的评估
The Evaluation of MTT Assay in vitro for Prediction of the Correlativity between the sensitivity of Chemotherapeutic Agents in vitro and the Effect in vivo on Ovarian Epithelial Carcinoma
-
卵巢上皮癌Ⅲ期术后≤2cm残留灶的治疗与预后
Stage ⅲ epithelial ovarian cancer with residual tumor ≤ 2 ? Cm after primary surgery
-
结论:MTT法对卵巢上皮癌的个体化治疗计划有参考价值,能在一定程度上指导临床用药。
Conclusion : The MTT assay in vitro has a referenced value for the individualized regimens on ovarian epithelioma and can , to some extent , direct the clinical medication .
-
目的:探讨卵巢上皮癌组织中环氧合酶-2(COX-2)表达及其与微血管密度(MVD)的关系。
Objectives : To research the expressions of cyclooxygenase-2 ( COX-2 ) in cancer tissues of human epithelial ovarian and its relations with the microvascular density ( MVD ) .
-
卵巢上皮癌组患者血清TSGF水平高于其他类型卵巢癌;
The levels of TSGF in the patients with epithelial ovarian cancer than those with any other types of ovarian cancer ;
-
结论IFO联合化疗是治疗复发或未控、特别是对PDD敏感的卵巢上皮癌、宫颈鳞癌以及子宫肉瘤的有效方案。
Conclusion IFO combination chemotherapy is effective in treating recurrent or progressive gynecologic malignancies , especially PDD sensitive ones .
-
异环磷酰胺联合自体PHA-LAK细胞治疗晚期复发卵巢上皮癌的疗效观察
Ifosfamide with PHA-LAK cell adoptive immunotherapy in advanced recurrent ovarian epithelial cancer
-
方法从1984年1月至1998年12月治疗Ⅲ、Ⅳ期卵巢上皮癌120例。病例除手术治疗外还全部用FPM(5-Fu、DDP、MMC)化疗方案化疗。
Methods From Jan.1984 to Dec.1998 , 120 patients with stage ⅲ and stage ⅳ ovarian epithelial cancer received chemotherapy of FPM regimen besides surgical treatment .
-
COX-2及MUC-1的阳性表达与卵巢上皮癌的预后有关(P<0.05);
The over expression of COX-2 and MUC-1 were also correlated with prognosis of ovarian epithelial carcinoma ( P < 0.05 ) .
-
方法运用逆转录聚合酶链反应(RT-PCR)法,测定24例卵巢上皮癌、8例卵巢良性上皮肿瘤组织中LPA受体LPA1、LPA2、LPA3mRNA水平;
Methods RT-PCR was used to detect the mRNA expression of LPA receptors in the tissues of epithelial ovarian carcinoma ( 24 cases ) and benign epithelial ovarian tumor ( 8 cases ) .
-
目的:研究卵巢上皮癌(OEC)组织中人类白细胞抗原Ⅰ(HLAⅠ)、CD54和CD80的表达及其临床意义。
Objective : To investigate the expressions of human leukocyte antigen class ⅰ( HLA ⅰ), CD54 and CD80 in ovarian epithelial carcinoma ( OEC ) tissues and their clinical significance .